Boxed warning – HealthQuill

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

Merck announced it has got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form of kidney cancer.

USFDA green lights Merck’s drug to treat advanced kidney cancer

HQ Team December 15, 2023: Merck announced it got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form.

by HealthQuill
December 15, 2023
0 Comments

The USFDA has granted a standard approval for Eisai and Biogen's Alzheimer injection, Leqembi —the first treatment to secure the traditional approval, paving the way for wider insurance coverage of the drug.

Drugs Health Pharma

USFDA grants green light to Eisai, Biogen’s Alzheimer’s drug Leqembi

HQ Team July 7, 2023: The USFDA has granted a standard approval for Eisai and Biogen’s Alzheimer injection, Leqembi —the first treatment to secure the.

by HealthQuill
July 7, 2023
0 Comments

About Us

Contact Info

Follow Us

USFDA green lights Merck’s drug to treat advanced kidney cancer

USFDA grants green light to Eisai, Biogen’s Alzheimer’s drug Leqembi